Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Special investigation of J Zoloft [sertraline] for panic disorder patients.

Trial Profile

Special investigation of J Zoloft [sertraline] for panic disorder patients.

Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2012

At a glance

  • Drugs Sertraline (Primary)
  • Indications Panic disorder
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Oct 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
    • 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 22 Aug 2011 Planned end date changed from 1 Nov 2010 to 1 Nov 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top